Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Mithra Pharmaceuticals Total Assets (Quarterly): 407.25M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 407.25M |
| June 30, 2023 | 407.25M |
| December 31, 2022 | 474.44M |
| June 30, 2022 | 451.79M |
| June 30, 2022 | 451.79M |
| December 31, 2021 | 477.70M |
| June 30, 2021 | 519.56M |
| June 30, 2021 | 519.56M |
| December 31, 2020 | 642.02M |
| June 30, 2020 | 474.01M |
| June 30, 2020 | 474.01M |
| December 31, 2019 | 445.43M |
| June 30, 2019 | 421.14M |
| June 30, 2019 | 421.14M |
| Date | Value |
|---|---|
| December 31, 2018 | 411.49M |
| June 30, 2018 | 341.63M |
| June 30, 2018 | 341.63M |
| December 31, 2017 | 293.58M |
| June 30, 2017 | 245.77M |
| June 30, 2017 | 245.77M |
| December 31, 2016 | 182.57M |
| June 30, 2016 | 201.88M |
| June 30, 2016 | 201.88M |
| December 31, 2015 | 224.77M |
| June 30, 2015 | 103.89M |
| June 30, 2015 | 103.89M |
| December 31, 2014 | 19.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
407.25M
Minimum
Jun 2023
642.02M
Maximum
Dec 2020
470.51M
Average
462.90M
Median
Total Assets (Quarterly) Benchmarks
| Galapagos NV | 4.710B |
| UCB SA | 17.18B |
| Nyxoah SA | 122.05M |
| Celyad Oncology SA | 13.23M |
| MDxHealth SA | 121.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 416.74M |
| Shareholders Equity (Quarterly) | -9.487M |
| Debt to Equity Ratio | -19.15 |
| Current Ratio | 1.043 |
| Net Debt Paydown Yield | 1.08% |